Regulatory News
Friday, June 24, 2016
U.S. FDA panel to vote whether diabetes drug cuts cardiac death
June 24 (Reuters) - An advisory panel to the U.S. Food and
Drug Administration will be asked to vote next week on whether a
diabetes drug made by Eli Lilly & Co and Boehringer
Ingelheim cuts the risk...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment